Filter
327
Filtered Results: 327
Text search:
mRNA
Featured
Recommendations
62
New Publications
9
Language
Document type
Guidelines
103
Fact sheets
65
Studies & Reports
44
No document type
37
Videos
29
Manuals
13
Resource Platforms
11
Strategic & Response Plan
10
Training Material
5
Infographics
5
Situation Updates
3
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
17
Russia
12
Global
11
Ukraine
9
Latin America and the Carribbean
9
Middle East and North Africa
7
India
7
South Africa
6
Ecuador
5
Syria
4
Nigeria
4
Argentina
4
Yemen
4
Senegal
3
Mozambique
3
Africa
3
Lebanon
3
Eastern Europe
3
China
2
Kazakhstan
2
Chile
2
Niger
2
Peru
2
Haiti
2
Western and Central Europe
2
Belarus
2
Uganda
2
Sudan
2
Mali
2
South Sudan
2
Somalia
2
Colombia
1
Kenya
1
Mexico
1
El Salvador
1
Benin
1
Sierra Leone
1
Rwanda
1
Cameroon
1
Congo-Brazzaville
1
Burkina Faso
1
Morocco
1
Qatar
1
Mauritania
1
Dominican Republic
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Nicaragua
1
Egypt
1
Ethiopia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Iraq
1
Liberia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
104
Clinical Guidelines
21
Public Health
8
Key Resources
8
Women & Child Health
4
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
COVID-19
206
Refugee
22
HIV
9
TB
9
Rapid Response
6
Mental Health
6
NTDs
5
Conflict
5
Ebola & Marburg
4
Pharmacy
3
Health Financing Toolbox
3
NCDs
2
Specific Hazards
1
Planetary Health
1
Zika
1
Global Health Education
1
AMR
1
Verfügbar in Deutsch, Französisch, Italienisch und Englisch
Vacunas
recommended
COVID Reference 23 May 2021
Information about vaccine administration
Vaccines
recommended
COVID Reference 23 May 2021
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
Mythes & COVID-19 Vaccins
recommended
MEDBOX Dossier no. 16. 28 Sept 2021.
De nombreuses études ont montré l'efficacité de la vaccination contre le COVID-19 et le fait qu'elle protège contre les maladies graves.
maladie grave. Un taux de vaccination élevé est nécessaire pour combattre la pandémie dans le monde entier. En raiso...
Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppen sowie zu Wechselwirkungen und Nebenwirkungen von Impfstoffen und Arzneimitteln zu COVID-19 und SARS-CoV-2
Verfügbar in Deutsch, Französisch, Italienisch und Englisch
Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppe sowie zu Wechselwirkungen und Nebenwirkungen.
Available in English, German, French and Italian
обновленная версия от 04/10/2021
Информация о введении вакцин
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
